24X7 Healthcare Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 15-12-2024
- Paid Up Capital ₹ 0.10 M
as on 15-12-2024
- Company Age 4 Year, 24 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.05 Cr
as on 15-12-2024
- Revenue %
(FY 2022)
- Profit -56245.04%
(FY 2022)
- Ebitda -7069.24%
(FY 2022)
- Net Worth -16077.89%
(FY 2022)
- Total Assets 242.69%
(FY 2022)
About 24X7 Healthcare Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.05 Cr.
Alpana Ohri, Madhuri Malvadkar, and Joyshankar Ohri serve as directors at the Company.
- CIN/LLPIN
U85100MH2020PTC352645
- Company No.
352645
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Dec 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at 24X7 Healthcare Diagnostics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alpana Ohri  | Director | 28-Dec-2020 | Current |
| Madhuri Malvadkar | Director | 28-Dec-2020 | Current |
| Joyshankar Ohri | Director | 28-Dec-2020 | Current |
Financial Performance of 24X7 Healthcare Diagnostics.
24X7 Healthcare Diagnostics Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 56245.04% decrease in profit. The company's net worth observed a substantial decline by a decrease of 16077.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of 24X7 Healthcare Diagnostics?
In 2021, 24X7 Healthcare Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
City Medical & Lifestyle LlpActive 6 years 11 monthsAlpana Ohri and Joyshankar Ohri are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 21 May 2021 | ₹3.05 Cr | Open |
How Many Employees Work at 24X7 Healthcare Diagnostics?
24X7 Healthcare Diagnostics has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of 24X7 Healthcare Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped 24X7 Healthcare Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
